Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Development of Osteoarthritis Accelerated by Molecular Changes in the Bones

By LabMedica International staff writers
Posted on 28 May 2013
Development of osteoarthritis, a disease of the joints caused by degeneration of the cartilage, may depend as much on molecular changes in the underlying bone as it does on injury sustained by the cartilage.

Osteoarthritis is a highly prevalent and debilitating joint disorder thought to originate from instability in the load-bearing joints of the knee and hip caused by injury or strain. More...
There is no effective medical therapy for the condition because of limited understanding of its pathogenesis.

Investigators at Johns Hopkins University (Baltimore, MD, USA) felt that development of osteoarthritis must also be related to the changes in the underlying bone. To study this concept they worked with both bone cell cultures and a mouse osteoarthritis model.

They reported in the May 19, 2013, online edition of the journal Nature Medicine that ligament injury triggered damage in the subchondral bone that activated high levels of TGF-beta1 (transforming growth factor-beta1) protein, which recruited stem cells to the site so that they could create new bone to repair the damage. The additional bone stressed the cartilage above it and increased the rate of cartilage deterioration.

In the mouse model, it was seen that transgenic expression of active TGF-beta1 in osteoblastic cells induced osteoarthritis, whereas inhibition of TGF-beta activity in subchondral bone attenuated cartilage degeneration. In particular, knockout of the TGF-beta type II receptor (TbetaRII) led to less development of osteoarthritis relative to wild-type mice.

"If there is something wrong with the leg of your chair and you try to fix it by replacing the cushion, you have not solved the problem," said senior author Dr. Xu Cao, professor of orthopedic surgery at Johns Hopkins University. "We think that the problem in osteoarthritis is not just the cartilage "cushion,” but the subchondral bone underneath. That helped us to see the ways in which the bone was responding to changes in the cartilage and exacerbating the problem."

"Our results are potentially really good news for patients with osteoarthritis," said Dr. Cao. "We are already working to develop a clinical trial to test the efficacy of locally applied TGF-beta1 antibodies in human patients at early stages of osteoarthritis. If successful, this nonsurgical treatment could make osteoarthritis - and the pain and debilitation it causes - halt in its tracks."

Related Links:
Johns Hopkins University




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.